Active microneedle patch equipped with spontaneous bubble generation for enhanced rheumatoid arthritis treatment

Zhiyuan Liu, Jintao Fu, Ziyang Zheng, Minglong Chen, Wenhao Wang, Chuanbin Wu, Guilan Quan, Tingting PengTheranostics 2025 · DOI

Abstract

Rationale: The utilization of dissolving microneedles (MNs) facilitates the painless delivery of pharmaceuticals via the transdermal route. However, conventional MNs rely on passive diffusion through the gradual dissolving of the matrix, which can impede the therapeutic efficacy of the delivered drugs. Methods: In this study, we present the development of a novel degradable active MNs platform. This platform employs sodium bicarbonate and citric acid loaded in a dissolving MNs patch as a built-in motor for deeper and faster intradermal payload delivery. The sodium bicarbonate microparticles and citric acid undergo a chemical reaction when in contact with tissue fluid, resulting in the rapid formation of explosive carbon dioxide bubbles. This provides the necessary force to break through dermal barriers and enhance payload delivery. Results: The results demonstrated that the active MNs possessed excellent mechanical properties, rapid detachment characteristics, and superior drug release kinetics. Furthermore, the drug permeation behavior of active MNs exhibited enhanced permeation and distribution in skin-mimicking gel and porcine skin when compared to conventional passive MNs. In vivo experiments employing a rat model of rheumatoid arthritis showed that active MNs achieved superior therapeutic efficacy compared to passive MNs. Conclusions: This universal and effective autonomous dynamic microneedle delivery technology is straightforward to prepare and utilize, and has the potential to improve the therapeutic efficacy of drugs, offering significant prospects for a diverse range of therapeutic applications.

Introduction

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that necessitates long-term, precise management to prevent irreversible joint damage. Current clinical interventions typically involve oral medications or subcutaneous injections. However, oral delivery often leads to gastrointestinal distress and low bioavailability, while injections are painful, invasive, and require professional administration, leading to poor patient compliance.

Dissolving microneedles (MNs) have emerged as a promising, painless, and self-administrable alternative. Despite their potential, traditional "passive" MNs are limited by their reliance on the slow dissolution of the polymer matrix and simple diffusion. This results in sluggish drug release and requires the patch to be worn for extended periods. To address these limitations, this research introduces an "active" MN platform designed to overcome dermal barriers through autonomous mechanical force.

The "Micromotor" Mechanism

The core innovation of this platform is the integration of an effervescent "engine" within the needle tips. By incorporating sodium bicarbonate microparticles and citric acid into a polyvinylpyrrolidone (PVP) matrix, the researchers created a system that reacts spontaneously upon contact with interstitial fluid.

Schematic representation of the active microneedle patch mechanism for treating rheumatoid arthritis.

As moisture enters the needle, the chemical reaction generates carbon dioxide ($CO_2$) bubbles. This process acts as a built-in motor, providing the necessary force to drive the drug payload (in this case, Methotrexate) deeper and faster into the intradermal space. To prevent premature reaction during manufacturing, the team utilized anhydrous ethanol as a solvent, ensuring the effervescent components remained stable until application.

Experimental Validation

The team employed a multi-faceted approach to validate the active MNs:

  • Structural Analysis: Scanning Electron Microscopy (SEM) and EDX mapping confirmed the successful loading and distribution of the effervescent microparticles within the needle tips.
  • Fluid Dynamics: COMSOL Multiphysics simulations modeled the gas generation, confirming that the bubbles create vigorous local mixing and flow, which enhances drug transport.
  • In Vivo Efficacy: The patches were tested on an adjuvant-induced arthritis (AIA) rat model, comparing active MNs against oral delivery, subcutaneous injections, and passive MN patches.
Characterization and active delivery mechanism of the MNs, showing chemical distribution and bubble-driven release.

Key Results and Insights

Enhanced Release and Penetration

The active MNs demonstrated a "blistering" release speed. Within the first minute of application, the active MNs released 57.5% of their cargo, whereas passive MNs released a mere 1.2%. Confocal Laser Scanning Microscopy (CLSM) imaging of porcine skin showed that the bubble-driven mechanism achieved significantly wider and deeper drug distribution within 30 minutes compared to passive controls.

Rapid Detachment

A significant hurdle for MN technology is the required wear time. The bubble generation at the interface between the needle and the patch base weakens the structural attachment, allowing the drug-loaded tips to remain in the skin while the backing is removed in just 3 minutes. This is a substantial improvement over traditional patches that often require hours of wear.

Clinical Performance in RA Models

In the AIA rat model, the active MN group showed a 43.9% reduction in paw swelling, nearly matching the performance of subcutaneous injections (49.4%) and significantly outperforming oral delivery and passive MNs. Micro-CT scans further revealed that rats treated with active MNs had smoother joint surfaces and significantly less bone erosion, indicating superior protection of joint integrity.

Conclusion and Future Outlook

This study presents a universal and effective autonomous dynamic microneedle delivery technology. By transforming the microneedle from a static reservoir into an active vehicle, the researchers have significantly improved drug release kinetics and therapeutic outcomes for RA.

While the results are promising, future work must address the environmental sensitivity of the patches, as they require strictly anhydrous manufacturing and moisture-proof packaging. Additionally, further research is needed to determine if this active mechanism can be safely applied to larger biologics, such as monoclonal antibodies or vaccines, without compromising their structural integrity during the effervescent reaction. Nevertheless, this platform offers a powerful new tool for the transdermal delivery of a wide range of therapeutics.

Summary updated

Abstract

<b>Rationale:</b> The utilization of dissolving microneedles (MNs) facilitates the painless delivery of pharmaceuticals <i>via</i> the transdermal route. However, conventional MNs rely on passive diffusion through the gradual dissolving of the matrix, which can impede the therapeutic efficacy of the delivered drugs. <b>Methods:</b> In this study, we present the development of a novel degradable active MNs platform. This platform employs sodium bicarbonate and citric acid loaded in a dissolving MNs patch as a built-in motor for deeper and faster intradermal payload delivery. The sodium bicarbonate microparticles and citric acid undergo a chemical reaction when in contact with tissue fluid, resulting in the rapid formation of explosive carbon dioxide bubbles. This provides the necessary force to break through dermal barriers and enhance payload delivery. <b>Results:</b> The results demonstrated that the active MNs possessed excellent mechanical properties, rapid detachment characteristics, and superior drug release kinetics. Furthermore, the drug permeation behavior of active MNs exhibited enhanced permeation and distribution in skin-mimicking gel and porcine skin when compared to conventional passive MNs. <i>In vivo</i> experiments employing a rat model of rheumatoid arthritis showed that active MNs achieved superior therapeutic efficacy compared to passive MNs. <b>Conclusions:</b> This universal and effective autonomous dynamic microneedle delivery technology is straightforward to prepare and ultilize, and has the potential to improve the therapeutic efficacy of drugs, offering significant prospects for a diverse range of therapeutic applications.
BibTeX
@inproceedings{liu2025active,
  author = {Zhiyuan Liu and Jintao Fu and Ziyang Zheng and Minglong Chen and Wenhao Wang and Chuanbin Wu and Guilan Quan and Tingting Peng},
  title = {{Active microneedle patch equipped with spontaneous bubble generation for enhanced rheumatoid arthritis treatment}},
  booktitle = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.103080},
}
Figure